Brief: Nabriva Therapeutics Announces Date Of 1-For-10 Reverse Stock Split
Dec 2 (Reuters) - Nabriva Therapeutics PLC NBRV.O :
* NABRIVA THERAPEUTICS ANNOUNCES DATE OF 1-FOR-10 REVERSE
STOCK
SPLIT
* NABRIVA THERAPEUTICS PLC - WILL EFFECT A 1-FOR-10 REVERSE
STOCK
SPLIT OF ITS ORDINARY SHARES AS OF COMMENCEMENT OF TRADING ON
DECEMBER 3, 2020
Source text for Eikon: ID:nGNX7dKwzv
Further company coverage: NBRV.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nabriva Therapeutics
See all newsBrief: Nabriva Therapeutics And Units Enter Asset Purchase Agreement With Sumitomo Pharma
Brief: Nabriva Therapeutics Says Received Delisting Determination Letter From Nasdaq
Brief: Nabriva Therapeutics Receives Notice Of Delisting Or Failure To Satisfy Continued Listing Rule From Nasdaq
Brief: Nabriva Therapeutics - On Jan 31, Co's Unit Entered Into Letter Agreement With 2 Units Of Merck & Co, About Distribution Agreement, Dated July 15, 2020
Brief: Nabriva Therapeutics Provides Corporate Update